Mbc2 Inhibitors
Chemical inhibitors of Mbc2 encompass a range of compounds that target different signaling pathways and kinases, potentially affecting the function of Mbc2 through various mechanisms. Staurosporine, a broad-spectrum protein kinase inhibitor, can disrupt the phosphorylation process essential for the activity of Mbc2, leading to its inhibition. Bisindolylmaleimide I, specifically inhibiting protein kinase C (PKC), can also impede the function of Mbc2 if its activity is modulated by PKC. Similarly, LY294002 and Wortmannin, both inhibitors of phosphoinositide 3-kinases (PI3K), can suppress Mbc2 activity by blocking PI3K signaling pathways, which may be integral to the function of Mbc2.
Additionally, PD98059 and U0126, which selectively inhibit MEK1/2, can lead to the inhibition of Mbc2 if the protein is regulated or activated by the MAPK/ERK pathway. Meanwhile, SB203580, targeting p38 MAP kinase, and SP600125, inhibiting JNK, could affect Mbc2 if it is a downstream effector of either of these MAP kinase pathways. PP2, an inhibitor of Src family tyrosine kinases, can decrease Mbc2 function if Src kinase signaling plays a role in the regulation of Mbc2. The activities of EGFR and HER2/neu are targeted by Lapatinib, and EGFR tyrosine kinase is inhibited by Gefitinib; the inhibition of these receptors can lead to decreased Mbc2 activity if it is involved in their signaling pathways. Lastly, Rapamycin's inhibition of mTOR, a key molecule in cell growth and metabolism, can lead to the inhibition of Mbc2 if the protein's function is regulated through mTOR signaling pathways. Each of these inhibitors targets specific kinases or pathways that, if associated with the regulation or activity of Mbc2, can effectively inhibit the protein's function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent protein kinase inhibitor that can inhibit a wide range of kinases. Given the typical involvement of kinases in protein signaling pathways, staurosporine may inhibit the phosphorylation process required by Mbc2. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This compound is a specific inhibitor of protein kinase C (PKC), and if Mbc2 is regulated by or interacts with PKC as a part of its function, this inhibitor could disrupt that interaction, leading to inhibition of Mbc2 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of phosphoinositide 3-kinases (PI3K). If Mbc2's function is PI3K-dependent, or if PI3K signaling modulates Mbc2's activity, then inhibition of PI3K by LY294002 could lead to inhibition of Mbc2. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
As a MEK inhibitor, PD98059 may inhibit the MAPK/ERK pathway. If Mbc2 is activated or regulated by the MAPK/ERK pathway, then inhibiting this pathway would result in the functional inhibition of Mbc2. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAP kinase. If Mbc2 is a downstream effector of p38 MAP kinase activity, inhibition of this kinase by SB203580 could lead to inhibition of Mbc2 activity. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases. If Mbc2 activity is regulated by Src kinase signaling, inhibition by PP2 could lead to decreased Mbc2 function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor. Similar to LY294002, if Mbc2 requires PI3K signaling for its function, inhibition of PI3K by Wortmannin would lead to inhibition of Mbc2 activity. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
Lapatinib inhibits the tyrosine kinase domains of EGFR and HER2/neu. If Mbc2 is involved in pathways regulated by these receptors, its activity may be inhibited by Lapatinib due to disruption of upstream signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of MEK1/2. If Mbc2 is activated as part of the MEK/ERK pathway, inhibition of MEK with U0126 would lead to functional inhibition of Mbc2. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which may affect the activity of Mbc2 if it is part of the JNK signaling pathway. Inhibition of JNK signaling would thus inhibit Mbc2 activity. | ||||||